Atlas Trials

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of SSS67 in Healthy Adult Participants Via Single Intravenous Infusion

Clinical trial NCT07487545 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07487545
Sponsor
Shenyang Sunshine Pharmaceutical Co., LTD.
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2026-03-31
Primary completion
2026-08-29
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.